- Advertisement -
Shares in Echo IQ Ltd (ASX: EIQ) have fallen 48% to after the company failed in its bid to get US Food and Drug Administration (FDA) approval for its heart failure decision support software EchoSolv HF.
Image source: Getty Images
Company to regroup after knockback
The…
